Vivocell is based in Switzerland aiming at enlarging the source of stem cells by establishing allogeneic umbilical cord blood (UCB) banks. The current operating units are in Graz, Austria and Langenfeld near Düsseldorf, Germany, with state-of-the-art laboratories and storage facilities licensed according to national tissue safety laws.

Vivocell – The legal Basis:

Austria: Tissue establishment according to § 22 and procurement for umbilical cord blood according to § 19 tissue safety law.

Germany: Umbilical cord blood bank and umbilical cord blood collection approval according to § 13 pharmaceutical law.

 

Vivocell laboratories process cord blood in compliance with cGMP and national standards.
In 2001 Vivocell, formerly Lifecord, was the first Austrian company that achieved a pharmaceutical law certificate for the collection, processing and banking of stem cells from umbilical cord blood.
In addition to the processing and banking facilities, a fully equipped genetics department for the required tissue typing (HLA typing) is established in Graz. Since 2007 umbilical cord blood also from all over Germany can be processed and stored in Langenfeld near Düsseldorf. Know-how and consistent quality controle, meeting the high regulatory demands of the authorities, offer best possible manufacturing conditions and safety for the valuable stem cell preparation.